,
“Steady improvement in renal allograft survival among North American children. A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study,”, Kidney Int, vol. 48, pp. 551-53, 1995.
, “Steady improvement in renal allograft survival among North American children: a five year appraisal by the North American Pediatric Renal Transplant Cooperative Study.”, Kidney Int, vol. 48, no. 2, pp. 551-3, 1995.
, “Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.”, J Med Primatol, vol. 23, no. 2-3, pp. 184-225, 1994.
, “Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040.”, Neuroepidemiology, vol. 13, no. 4, pp. 179-86, 1994.
, “First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.”, J Med Primatol, vol. 22, no. 2-3, pp. 203-35, 1993.
, “Five-year patient and graft survival in North American children: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Kidney Int Suppl, vol. 43, pp. S16-21, 1993.
, “Male-female differences in the impact of cancer therapy.”, Oncology (Williston Park), vol. 7, no. 2, pp. 67-74; discussion 74, 77, 1993.
, “Projected neurodegenerative disease mortality in the United States, 1990-2040.”, Neuroepidemiology, vol. 12, no. 4, pp. 219-28, 1993.
, “Assessing quality of life in head and neck cancer.”, Qual Life Res, vol. 1, no. 1, pp. 5-17, 1992.
, “Building quality of life assessment into cancer treatment studies.”, Oncology (Williston Park), vol. 6, no. 6, pp. 25-8; discussion 30-2, 37, 1992.
, “Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.”, J Natl Cancer Inst, vol. 84, no. 8, pp. 575-9, 1992.
, “Recovery of renal function in continuous ambulatory peritoneal dialysis: a study of National CAPD Registry data.”, Perit Dial Int, vol. 12, no. 1, pp. 43-7, 1992.
, “Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.”, J Med Primatol, vol. 21, no. 2-3, pp. 139-86, 1992.
, “Assessment of family history information in case-control cancer studies.”, Am J Epidemiol, vol. 133, no. 8, pp. 757-65, 1991.
, “Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error.”, Biometrics, vol. 47, no. 2, pp. 523-33, 1991.
, “Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase.”, J Med Chem, vol. 33, no. 2, pp. 543-52, 1990.
, “Challenges of HIV vaccine development.”, Stat Med, vol. 9, no. 12, pp. 1425-31; discussion 1433-7, 1990.
, “Hematocrit values in the CAPD/CCPD population: a report of the National CAPD Registry.”, Perit Dial Int, vol. 10, no. 4, pp. 275-8, 1990.
, “Mesothelioma in Cyprus.”, IARC Sci Publ, no. 90, pp. 411-9, 1989.
, “The Mid-Atlantic Oncology Program's comparison of two data collection methods.”, Control Clin Trials, vol. 10, no. 3, pp. 282-9, 1989.
, “Rilmenidine and vigilance. Review of clinical studies.”, Am J Med, vol. 87, no. 3C, p. 67S-72S, 1989.
, “Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry.”, Am J Kidney Dis, vol. 14, no. 1, pp. 44-9, 1989.
, “The 1987 USA National CAPD Registry report.”, ASAIO Trans, vol. 34, no. 2, pp. 150-6, 1988.
, “Current concepts. Continuous ambulatory peritoneal dialysis.”, N Engl J Med, vol. 318, no. 24, pp. 1595-600, 1988.
,